MAPT and Alzheimer disease: This negative correlation between α4β2* receptors – Aβ plaques and α4β2* receptors – Tau suggests a potential useful complimentary role of imaging α4β2* receptors as different indicators of AD that track and confirm AD progression (Fig. 9).